TLR4 and necrotizing enterocolitis: Several animal studies using experimental models of NEC have shown that LCPUFA supplementation results in reduced NEC incidence and its severity by regulating multiple pathways associated with intestinal inflammation/injury and necrosis, including TLR4, platelet-activating factor, and nuclear factor-κB [81,82,83].